Medicen Paris Region is a competitiveness cluster (non-profit organization) for innovative health technologies with national and international scope. With more than 440 companies, research centers, universities, hospitals and local authorities as members, it aims to position the Paris region as Europe’s leading healthcare cluster. It focuses on five strategic areas and on combined therapeutic solutions that will mix several of these areas with precision medicine: biological diagnostics, diagnostic and interventional imaging, biotherapies (cellular & genic therapies, bioprodcution), digital health (AI...) and the development of techno-therapies (treatment via technologies, such as connected implants or artificial organs).
Since the creation of the cluster, 80 innovative products have been launched in biological tools sectors, imaging, and medical devices. The cluster has certified 335 projects. They received funding from the French government (French Inter-Ministry Fund, Structural Projects fund for Competitiveness), the public investment bank bpifrance, the National Research Agency, the European Regional Development Fund, the Investments for the Future program and/or local authorities, and the Paris Region. Total investment is close to €1.9 billion ($2.2bn) and €708 million ($803M) of public aid.